|
Sacco, R L; Owen, J; Mohr, J P et al. (1989) Free protein S deficiency: a possible association with cerebrovascular occlusion. Stroke 20:1657-61
|
|
Bini, A; Fenoglio Jr, J J; Mesa-Tejada, R et al. (1989) Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9:109-21
|
|
Bini, A; Mesa-Tejada, R; Fenoglio Jr, J J et al. (1989) Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies. Lab Invest 60:814-21
|
|
Kaplan, K L; Mather, T; DeMarco, L et al. (1989) Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Arteriosclerosis 9:43-9
|
|
Owen, J; Grossman, B A; Palmer, R H (1988) Hyperlipidemia and in vivo hemostatic system activation. Semin Thromb Hemost 14:241-5
|
|
Owen, J; Friedman, K D; Grossman, B A et al. (1988) Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood 72:616-20
|
|
Sobel, J H; Thibodeau, C A; Canfield, R E (1988) Early alpha chain crosslinking in human fibrin preparations. Thromb Haemost 60:153-9
|
|
Sobel, J H; Thibodeau, C A; Gawinowicz Kolks, M A et al. (1988) Immunochemical characterization of crosslinked derivatives isolated from alpha chain oligomers formed during early stages of fibrin crosslinking. Thromb Haemost 60:160-9
|
|
Owen, J; Friedman, K D; Grossman, B A et al. (1987) Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator. J Clin Invest 79:1642-7
|
|
Bini, A; Fenoglio Jr, J; Sobel, J et al. (1987) Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 69:1038-45
|
Showing the most recent 10 out of 29 publications
